Rubicon Research Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Rajendra Mhaske, was filed 17 Jun 2026.
Rubicon Research: what insiders have been doing
Rubicon Research belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). From 23 October 2025 to 23 October 2026, the disclosure feed for Rubicon Research logged 25 filings by 9 insiders.
Purchases and sales both appear in the filings: 1 purchase (1 insider, €11) and 22 sales (9 insiders, €209.3M). The net balance comes to €209.3M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a sale of €206.5M from General Atlantic Singapore RR Pte Ltd, disclosed on 28 August 2026, or 8.0% of market capitalisation.
With 25 filings in twelve months, the company is more active than the median of 4 filings across the 1,892 companies we follow on the same exchange. The full history, which starts in 2026, counts 1 purchase against 22 sales.
The last purchase on record was published on 17 June 2026, which is 145 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySale+2 other insiders
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 3,000 shares@ ₹1,829.800.0021% mcap44.5% of flowEquityMarket SaleSEBI:bed15a80a8fb778819fda9b249b2afcfe593282b
- 1,500 shares@ ₹1,821.000.0011% mcap22.1% of flowEquityMarket SaleSEBI:a62e3bf25c759a5d8c20f81f67b5a867636b9f39
- 1,296 shares@ ₹1,788.500.0009% mcap18.8% of flowEquityMarket SaleSEBI:4d1f2409bd4f93326179e8cf8a7120ba4c2c36a7
- 1,000 shares@ ₹1,809.900.0007% mcap14.7% of flowEquityMarket SaleSEBI:1f33d51eeafcaba39b955046e7f47383f2bef1c1
- 13,853,073 shares@ ₹1,660.008.04% mcap98.9% of flowEquityMarket SaleSEBI:8f458f05f56e806c39cc2af09680799bb7380a79
- 146,927 shares@ ₹1,729.800.089% mcap1.1% of flowEquityMarket SaleSEBI:83dd7d451f8b69e5c32c423419aa95e19e9e86ab
- 4,000 shares@ ₹1,752.500.0024% mcap66.2% of flowEquityMarket SaleSEBI:947504a36719d64225ca16ee8f0768b54133c56a
- 2,000 shares@ ₹1,790.500.0012% mcap33.8% of flowEquityMarket SaleSEBI:ca153d74059989b02dd6d3dfd2f530b999abd555
- 35,000 shares@ ₹0.100.0000% mcap57.8% of flowEquityMarket SaleSEBI:0326ea4ee3d634ed8c2cb0019479932875472f89
- 10,000 shares@ ₹0.100.0000% mcap100.0% of flowEquityMarket SaleSEBI:9b3c00a4d5fd8184906b29528c753412f5ab8a45
- 20,000 shares@ ₹1,408.600.010% mcap40.0% of flowEquity SharesMarket SaleSEBI:48c0fb3cc262e539f25ca97e45ddf7ae705d1e32
- 20,000 shares@ ₹1,410.600.010% mcap40.0% of flowEquity SharesCreation Of PledgeSEBI:20db77c18aff1d23d47d035fccec38cbeb034e7f
- 10,000 shares@ ₹1,408.600.0051% mcap20.0% of flowEquity SharesCreation Of PledgeSEBI:9e08734051629ceae420434560e9c2beaef9513f
- 2,282 shares@ ₹0.600.0000% mcap100.0% of flowEquity SharesMarket SaleSEBI:077dc191728b41ebab0724aa89c7ced1501de07a
- 780 shares@ ₹1.7025.4% of flowEquity SharesMarket SaleSEBI:94dd295231e98c629e0875d8d2d035652a873a8f
- 50 shares@ ₹26.1017.4% of flowEquity SharesMarket SaleSEBI:ba9b6bb3d28635ebcdfeea6c5f51aeb486e55b24
- 600 shares@ ₹2.0023.5% of flowEquity SharesMarket SaleSEBI:2b7864b5c82aab1b4fe4534986a025d78589eba8
- 3,000 shares@ ₹0.4016.8% of flowEquity SharesMarket SaleSEBI:915f732345e4228ba68a89da5842df9fe2fe72a0
- 1,400 shares@ ₹0.9025.2% of flowEquity SharesMarket SaleSEBI:abf88cfe69d7a1dab76d7869c592f18f69834299
- 2,000 shares@ ₹0.6016.5% of flowEquity SharesMarket SaleSEBI:e9f69b11c65861ab5a48f0babbbf8f6564d4eed6
- 1,000 shares@ ₹1.2016.1% of flowEquity SharesMarket SaleSEBI:d0ae58252f0325f0326c228effbd80450bf24f47
- 16 shares@ ₹74.4015.9% of flowEquity SharesMarket PurchaseSEBI:2a149356b1b9638a72dfb3dfdac9995e3d1354ceCanonical exit: 15 Sept 2026 (T+90)
- 2,000 shares@ ₹0.7017.4% of flowEquity SharesMarket SaleSEBI:0f994189c568c98382bec751509f403d60eb31f3
- 1,222 shares@ ₹1.1025.9% of flowEquity SharesMarket SaleSEBI:6276c4f277bdd42c8e608cc32ee88090d84611e7
- 15,094 shares@ ₹0.1042.2% of flowEquity SharesMarket SaleSEBI:61f57d9e57ff7ca64717388f0ffa58e00d096b84
25 of 25 declarations
About Rubicon Research
Rubicon Research is a company listed on the XBOM, specializing in research and development in the financial sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
